Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

NCT03621670 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1196

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL: Bexsero (GSK Biologicals' Meningococcal group-B vaccine/ rMenB+OMV NZ)
BIOLOGICAL: Prevnar13
BIOLOGICAL: Pediarix
BIOLOGICAL: Hiberix
BIOLOGICAL: Rotarix
BIOLOGICAL: M-M-R II
BIOLOGICAL: Varivax
BIOLOGICAL: Placebo (saline water)
BIOLOGICAL: Prevnar 20

Sponsor

GlaxoSmithKline